Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Higher ultra-processed food intake aligns with greater binge eating risk in obesity study

New clinical research links ultra-processed food consumption with disordered eating patterns and poorer diet quality in adults with obesity, highlighting potential targets for improved nutritional intervention. Study: Higher consumption of ultra-processed food

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

New clinical research links ultra-processed food consumption with disordered eating patterns and poorer diet quality in adults with obesity, highlighting potential targets for improved nutritional intervention.

Study: Higher consumption of ultra-processed foods is associated with disordered eating symptoms and low-quality diet in adults with obesity. Image Credit: Inna Tarnavska / Shutterstock

In a recent cross-sectional study published in the Archives of Endocrinology and Metabolism, researchers examined ultra-processed food (UPF) intake and its association with eating behavior in adults with obesity in São Paulo, Brazil.

Nutritional Transition and Ultra-Processed Food Consumption

Nutritional transition is increasingly observed in developing countries due to demographic, economic, cultural, and social shifts. This transition is marked by reductions in malnutrition and infectious diseases but a parallel rise in noncommunicable diseases, including obesity. These changes are largely driven by higher consumption of fat- and sugar-rich, industrially processed foods.

High intake of ultra-processed foods (UPFs) has been linked to increased prevalence of obesity, overweight, type 2 diabetes, metabolic syndrome, cardiovascular and cerebrovascular disease, anxiety, depression, and all-cause mortality. Emerging evidence suggests UPFs may alter eating behavior by affecting neurobiological and endocrine pathways involved in appetite regulation, potentially promoting compulsive overeating.

Eating disorders and disordered eating patterns can occur in individuals with obesity and may negatively influence the effectiveness of weight management interventions. Understanding how UPF consumption relates to eating behavior is therefore clinically relevant.

Study Design and Participant Characteristics

The study recruited adults aged 18-59 years with obesity, defined as body mass index (BMI) ≥ 30 kg/m², from a clinical obesity treatment service and via social media in São Paulo. Exclusion criteria included pregnancy, diagnosed eating disorders, cardiac or renal disease, obesity secondary to genetic disorders, use of antiepileptic drugs or corticosteroids, smoking, alcohol abuse, and ongoing pharmacological weight loss treatment.

Dietary intake was assessed using the mean of three non-consecutive 24-hour dietary recalls conducted with the multiple-pass method, including one weekend day. Foods were categorized using the NOVA classification system to determine the degree of industrial processing. Diet quality was evaluated using the Diet Quality Index associated with the Digital Food Guide.

Eating behavior was assessed through validated self-administered online questionnaires.

  • BITE, measuring bulimia and binge eating symptoms and severity
  • TFEQ-21, assessing cognitive restraint, emotional eating, and uncontrolled eating
  • DEBQ, evaluating external, emotional, and restrained eating

Associations between UPF intake and eating behavior were analyzed using generalized linear models.

Prevalence of Unusual Eating Behaviors

A total of 77 adults participated, 78% of whom were female. The mean age was 36 years, and the mean BMI was 39.14 kg/m², consistent with class II obesity on average.

Participants were divided into tertiles based on the proportion of calories derived from UPFs.

  • First tertile: < 24.1% of calories from UPFs
  • Second tertile: 24.1%-35.4%
  • Third tertile: > 35.4%

Only about one-quarter of participants demonstrated normal eating behavior. Approximately 52% exhibited unusual eating behavior, and 23.4% reported binge eating. Across all tertiles, symptoms consistent with unusual eating were observed. The highest UPF tertile had significantly higher BITE symptom subscale scores compared with the lowest tertile, although severity scores did not significantly differ across groups.

Overall, 40.3% of participants had clinically significant symptoms, and 13% presented severe symptoms.

Eating Style Patterns and UPF Intake

Regarding eating styles, 37.8% of participants had elevated external eating scores, 36.5% had elevated emotional eating scores, and 25.7% had elevated restrained eating scores. On the TFEQ-21, 52% demonstrated higher emotional eating, 29.3% showed increased cognitive restraint, and 18.7% exhibited higher uncontrolled eating.

UPF intake was positively associated with binge eating and bulimia symptoms measured by BITE, emotional eating, external eating, and uncontrolled eating. These findings suggest that higher consumption of ultra-processed foods is associated with eating behaviors characterized by reduced self-regulation and heightened responsiveness to emotional and environmental cues.

Diet Quality and Macronutrient Intake

Diet quality was classified as intermediate across the overall sample and within the first and second UPF tertiles. Individuals in the highest UPF tertile had significantly lower diet quality scores than those in the lower tertiles.

The first tertile consumed more unprocessed or minimally processed foods, while the third tertile consumed a greater proportion of UPFs. The first and second tertiles reported higher intake of processed culinary ingredients compared with the third tertile.

Mean macronutrient distribution was 20% protein, 48% carbohydrates, and 32% lipids. The third tertile had significantly lower protein intake than the other tertiles, whereas carbohydrate and lipid intake did not significantly differ across groups. Median total caloric intake was 1,661 kcal, with higher caloric intake observed in the third tertile compared with the second.

Higher UPF intake was associated with poorer diet quality and reduced protein intake, which may influence satiety and appetite regulation.

Clinical Implications and Study Limitations

The study found that more than half of adults with obesity demonstrated unusual eating behaviors. Higher UPF intake was associated with binge eating, bulimia-related symptoms, emotional eating, external eating, and uncontrolled eating. Greater UPF consumption also correlated with lower diet quality and reduced protein intake.

These findings suggest that obesity treatment strategies should incorporate assessment of diet quality and eating behavior dimensions that may predispose individuals to unhealthy food choices. Addressing behavioral drivers alongside dietary composition may improve weight management outcomes.

Because this was a cross-sectional study conducted in a clinical sample from a single urban center, causal relationships cannot be established. Self-reported dietary recalls and questionnaires may introduce recall and social desirability bias. The small sample size and predominantly female composition may further limit generalizability.

Overall, the results highlight the need to consider ultra-processed food consumption within a broader behavioral and nutritional framework for obesity management, while acknowledging the observational nature of the findings.

  • Favaron CM, Mônico-Neto M, Antunes HKM, et al. (2026). Higher consumption of ultra-processed foods is associated with disordered eating symptoms and low-quality diet in adults with obesity. Archives of Endocrinology and Metabolism, 70(2). DOI: 10.20945/2359-4292-2026-0010 https://www.aem-sbem.com/article/higher-consumption-of-ultra-processed-foods-is-associated-with-disordered-eating-symptoms-and-low-quality-diet-in-adults-with-obesity/

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Why do so many of the compounds fail?

One of the main reasons why compounds fail is that they actually don't work in the patients they are tested in. We may have picked the wrong target since although we've actually created a molecule that, for example, inhibits the activity of the protein in the disease, it may actually turn out that over activity of that e protein isn't as important as we thought it was in that disease. The other reasons molecules fail now is primarily unexpected toxicity. You could take a molecule all the way through to phase 3 trials – the biggest trials in patients – and suddenly find that in your long-term, two-year carcinogenicity studies in animals, that you've got something that is quite cancer-provoking, so you have to stop development. Those are the two reasons: efficacy and toxicity. Somehow, we've got to find a way of trying to increase the chances of success or making the process less costly and leaner.

Source: www.news-medical.net ↗
02What is carb cycling?

Carb cycling is an attempt to fine-tune your carbohydrate consumption to alter many aspects of your metabolism. Your plan will include the same protein intake each day but vary carbohydrates according to your activity. Your carb cycling plan may have three low or zero carb days, two moderate carb days, and two high carb days. Meeting your calorie requirements will require including more fats on low-carb days. Carb cycling needs much more planning than a usual calorie-controlled diet. One way is to match your carb cycling to your physical activity. If you go to the gym thrice a week, you could have carbs on those days. The carbs provide energy for your workout, prevent fatigue, and avoid the muscle loss sometimes seen with dieting. The days when you eat little to no carbs force your body to generate energy from other sources, like proteins and fats. But the days when you eat more carbohydrates might reverse this change. You must only eat a high-carb diet on the days you have a heavy workout, which uses up the calories.

Source: www.medicinenet.com ↗
03With graph neural networks, foundation models, and diffusion models transforming the field, what can we predict reliably today that was difficult a decade ago and are there still any blind spots?

One major example is protein structure. Methods such as AlphaFold and Boltz-2 have transformed how we generate 3D structural data. Accurate protein structure prediction has been a decades-old challenge, and while there is still work to do on underrepresented protein classes, these models have opened an extraordinary pathway. We have also seen progress in multi-output models. Just over a decade ago (circa 2013), toxicology and property prediction models often focused on one endpoint at a time. Now, multi-output models, especially from methods such as graph neural networks (GNNs) and other deep learning methods, can predict multiple endpoints simultaneously. This allows for transfer learning between related properties. That creates opportunities across ADMET (absorption, distribution, metabolism, excretion, and toxicity) prediction and toxicology. Another exciting area is machine learning potentials. Molecular simulations traditionally rely on fixed mathematical functions to describe molecular interactions, but neural potentials can now replace or augment those functions. They can, in many cases, provide highly accurate simulations and structures at lower computational cost than quantum chemistry. However, its not just down to model architectures. The biggest blind spot behind all of these advances remains careful data curation, annotation, and collection. Open databases for example ChEMBL, PubChem and Chemspider together with data initiatives such as OpenADEMT and OpenBind to name but a few are making notable progress here. We still see some data for example on formulation chemistry often receiving less attention. Its is not just about data scale, but quality that is critical here to. Accessible high quality data sets are the fuel of AI methods. Architecture matters, but high-quality, accessible and abundant data is also absolutely critical.

Source: www.news-medical.net ↗
04How will this discovery change cancer science?

This is a win for the field. Until now, we have been focused on immune therapies that might make tumors more vulnerable to the body's immune system, and on finding new chemotherapy combinations that kill cancer cells. This new treatment has given us a new focus, and I think it will spur a lot of scientific discovery over the next few years. There have only been a handful of KRAS researchers and their relevance to therapy was always questioned. That is about to change. The most important next step for the field is to better understand the biology of cancer. We know that many pancreatic tumors will eventually become resistant to daraxonrasib, and we need to understand how this happens. We also need to identify additional genetic pathways and treatments that can target them. That's how we will turn pancreas cancer from a deadly, deadly cancer into something we can manage-and one day, even cure.

Source: www.news-medical.net ↗
05How does vitamin D strengthen the immune system?

More specifically, the study showed that the female patient produced very few cathelicidins, which is a natural toxin found in the immune cells of the lungs needed to fight tuberculosis. In most people infected by tuberculosis, tuberculosis bacteria attack the immune cells of the lungs. The immune cells fight the bacteria by eating them. But the tuberculosis bacterium has developed various evasive mechanisms that reduce the immune cells’ ability to digest and thus to kill the Mtb. “You could say that the tuberculosis bacterium has developed a way to lull the immune cells to sleep. This enables the disease the hide inside the immune cells, making it invisible to other parts of the immune system,” Martin Kongsbak-Wismann explains. This is where vitamin D enters the picture. Because vitamin D is able to counteract the soporific effect of the tuberculosis bacteria by making the immune cells produce more of the cathelicidin toxin. “Cathelicidin is like a microscopic needle that is able to pierce the tuberculosis bacteria. And when it does, it weakens the bacteria’s soporific effect on the immune cells. This restores the immune cells’ ability to kill tuberculosis bacteria,” says Martin Kongsbak-Wismann and adds: “We were amazed by the effect of vitamin D. In immune cells from healthy control subjects, vitamin D improved the cells’ ability to fight Mtb, whereas in the female patient’s immune cells we saw no response to vitamin D. This shows that vitamin D is key to the immune system’s ability to fight Mtb and prevent tuberculosis.” Al-Jaberi, F.A.H., et al. (2022) Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report. Frontiers in Immunology. doi.org/10.3389/fimmu.2022.1038960.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides